|
|
||||||||||||||
|
|
|||||||||||||||
SHORT REPORT |
Department of Clinical Biochemistry, The Ipswich Hospital, Heath Road, Ipswich, Suffolk IP4 5PD, UK
Correspondence to:
Dr Patrick J Twomey
Department of Clinical Biochemistry, The Ipswich Hospital, Heath Road, Ipswich, Suffolk IP4 5PD, UK; patrick.twomey@ipswichhospital.nhs.uk
31 January 2006
Keywords: CHD risk; HDL-C; accuracy; total error; tryglycerides
| The first 150 words of the full text of this article appear below. |
Several prospective clinical trials and epidemiological studies have shown that a low concentration of high-density lipoprotein-cholesterol (HDL-C) is an independent risk factor for coronary heart disease (CHD).1,2 It is estimated that for every 0.0259 mmol/l decrease in HDL-C, the relative risk of CHD events increases by 2–3%.3 Accordingly, HDL-C determinations are included in CHD prevention programmes.4 Reliable and easy to perform HDL-C assays are therefore required for routine laboratory practice.
There is often an inverse relationship between HDL-C and triglyceride concentrations. Accordingly, specimens with a low HDL-C often have a raised triglyceride concentration. HDL-C assay manufacturers often recommend dilution when the triglyceride is above a particular concentration. We decided to evaluate our routine HDL-C method to assess what triglyceride cut-off we should routinely utilise before specimen dilution.
HDL-C concentrations were determined using an anti human-ß-lipoprotein antibody that binds to non-HDL lipoproteins and allows the quantification of HDL-C by the presence
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS | REGISTER |
| Journal of Clinical Pathology | Molecular Pathology |